FIELD: organic chemistry, peptides, medicine, immunology, oncology, pharmacy. SUBSTANCE: invention describes peptide comprising specific epitope TLP of urogenital carcinoma where TLP comprises the following amino acid sequence: Gly-Pro-Pro-Glu-Val-Gln-Asn-Ala-Asn. Invention describes also reagents used for detection of indicated urogenital TLP and pharmaceutical composition containing indicated peptide. Invention allows to prepare peptides eliciting antigenic activity and to antibodies that are able to react with their and designated for using in diagnosticum and in clinics. EFFECT: valuable medicinal properties of peptide. 6 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIGENIC PEPTIDES, METHOD OF DETECTION OF PARTICLES SECRETED BY TUMORS | 1993 |
|
RU2141969C1 |
TLP-BASE IMMUNOGENIC COMPOSITION | 1997 |
|
RU2192274C2 |
NEW ANTIBODY SHOWING SPECIFICITY TO MALIGNANT LARGE INTESTINE TUMOR | 2001 |
|
RU2268068C2 |
DEVICES AND METHOD TO PRODUCE HIGHLY CLEANED NEUROTOXINS | 2010 |
|
RU2571212C2 |
IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY | 2013 |
|
RU2644686C2 |
ANTIBODY RAISED AGAINST TO HUMAN GASTROENTERIC TRACT EPITHELIAL TUMOR ANTIGEN RELATED WITH ALPHA-6,BETA-4-INTEGRIN | 2000 |
|
RU2266298C2 |
NEW CANCER ANTIGEN FOR EARLY DETECTION OF CANCER, METHOD FOR OBTAINING, ISOLATION AND DETECTION THEREOF | 2020 |
|
RU2818471C2 |
ANTIBODY FRAGMENTS SPECIFIC IN RELATION TO HUMAN CANCER-EMBRYONIC ANTIGEN (CEA) | 2003 |
|
RU2294939C2 |
ANTIBODIES USEFUL IN DIAGNOSING CANCER | 2018 |
|
RU2815883C1 |
ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER DIAGNOSIS | 2013 |
|
RU2661772C2 |
Authors
Dates
2003-05-10—Published
1997-07-02—Filed